HOME >> BIOLOGY >> NEWS
Dr. Thomas Starzl receiving prestigious King Faisal International prize this week in Saudi Arabia

Transplant pioneer Thomas E. Starzl, M.D., Ph.D., professor of surgery at the University of Pittsburgh School of Medicine, will accept one of the world's most prestigious awards, the King Faisal International Prize for Medicine, at a formal ceremony to be held Feb. 17 in Riyadh, Saudi Arabia, under the auspices of the King of Saudi Arabia.

According to the King Faisal Foundation, the largest philanthropic organization in the Middle East, the prize is in recognition of Dr. Starzl's outstanding contributions in the field of organ transplantation. He shares the award with two other transplant pioneers, Norman E. Shumway, M.D., a heart transplant surgeon from Stanford University, and Sir Roy Calne, a liver transplant surgeon from the University of Cambridge, United Kingdom. Each will receive a uniquely cast, commemorative 24-carat, 200-gram gold medal. The award's cash endowment of $200,000 will be divided among the three winners.

"Professor Starzl's pioneering work has influenced all aspects of organ transplantation," said officials from the Faisal Foundation when the winners of the prizes were announced in December.

Dr. Starzl performed the world's first liver transplant in 1963 at the University of Colorado. In 1962 and 1963, he introduced the concept of incorporating corticosteroids into the immunosuppression regimen for patients receiving kidney transplants from non-identical human living donors, which led to the largest series of kidney transplants and invigorated clinical attempts throughout the world. Lessons learned from kidney transplantation and other discoveries he made about liver physiology resulted in his performing the world's first successful liver transplant in 1967.

Since coming to the University of Pittsburgh in 1981, Dr. Starzl pioneered the immunosuppressive agent tacrolimus, resulting in significant improvements in organ transplant survival rates and allowing successful transplantation of the small intestine and multivisceral graf
'"/>

Contact: Lisa Rossi
rossil@msx.upmc.edu
412-647-3555
University of Pittsburgh Medical Center
11-Feb-2001


Page: 1 2 3

Related biology news :

1. UCRs Thomas Miller awarded prestigious medal from Academy of Sciences of the Czech Republic
2. Gene expression ratio identifies risk of recurrence in breast cancer patients receiving tamoxifen
3. DuPont part of science-based consortium receiving U.S. Dept. of Energy Bio-Refinery grant
4. Research shows different races, ethic groups receiving different levels of preventive care
5. Jefferson researchers find access to new methods of HIV prevention for pregnant women and newborns may depend on where they were receiving care
6. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award
7. Carnegie Mellon computational biologist Russell Schwartz receives prestigious CAREER award
8. Brown earns prestigious geography award
9. Ohio State wetlands professor wins prestigious Water Prize
10. Top US scientist honored with prestigious award
11. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award

Post Your Comments:
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
(Date:4/1/2015)... Medisafe ™, the leading global medication management platform with ... Android smartphones and tablets, announces today that ... allow patients to track and correlate their adherence directly ... be able to visualize in real-time how taking medication ... glucose levels and blood pressure. "Patients need ...
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has ... Market in Automotive Sector 2014-2018" report to their ... Recognition market in Automotive Sector to grow at a ... Gesture recognition is the ability of a device to ... Gesture recognition technology can be 2D-based or 3D-based. It ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
(Date:4/20/2015)... FOSTER CITY, Calif. , April 20, 2015 /PRNewswire/ ... with InterpretOmics Pvt. Ltd. to provide an integrated Big ... analysis of all biomarkers collected in the context of ... the needs of precise or multi-targeted drug candidates, stratified ... efficacy and disease progression free survival. ...
(Date:4/20/2015)... Portage Biotech Inc. ("Portage" or "the Company") (OTC Market: ... that its wholly owned subsidiary, Portage Pharmaceuticals Ltd. (PPL) ... of its proprietary human-derived CPP sequences and a cargo ... NFkB signalling even if administered when the BBB is ... brain barrier (BBB) in mice was studied and was ...
(Date:4/20/2015)... Whitehouse Laboratories is pleased and overly excited to ... and Drug Administration (FDA) inspection and received no observations ... compliance inspection, as based upon 21CFR Parts 210 and ... and was granted NAI (no action indicated) status. The ... Manufacturing Practice (GMP) quality system required by the regulatory ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 CIO Review ... for its 20 Most Promising Pharma and Life Science ... MMIS’s MediSpend global compliance software platform for life sciences ... selected by a panel of experts and members of ... entrepreneurship. “MMIS’s MediSpend Platform has been on our radar ...
Breaking Biology Technology:PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 3MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2
Cached News: